Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("CROSS, Nicholas C. P")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 77

  • Page / 4
Export

Selection :

  • and

Acquired Uniparental Disomy in Myeloproliferative NeoplasmsSCORE, Joannah; CROSS, Nicholas C. P.Hematology/oncology clinics of North America. 2012, Vol 26, Num 5, issn 0889-8588, vii, 981-991 [12 p.]Article

Signal transduction therapy in haematological malignancies : identification and targeting of tyrosine kinasesCHASE, Andrew; CROSS, Nicholas C. P.Clinical science (1979). 2006, Vol 111, Num 4, pp 233-249, issn 0143-5221, 17 p.Article

Aberrations of EZH2 in CancerCHASE, Andrew; CROSS, Nicholas C. P.Clinical cancer research (Print). 2011, Vol 17, Num 9, pp 2613-2618, issn 1078-0432, 6 p.Article

Myeloproliferative disorders with translocations of chromosome 5q31-35: Role of the platelet-derived growth factor receptor betaSTEER, E. Joanna; CROSS, Nicholas C. P.Acta haematologica. 2002, Vol 107, Num 2, pp 113-122, issn 0001-5792Article

Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndromeCHASE, Andrew; GRAND, Francis H; CROSS, Nicholas C. P et al.Blood. 2007, Vol 110, Num 10, pp 3729-3734, issn 0006-4971, 6 p.Article

Methylation-sensitive high-resolution melting-curve analysis of the SPRPN gene as a diagnostic screen for prader-willi and angelman syndromesWHITE, Helen E; HALL, Victoria J; CROSS, Nicholas C. P et al.Clinical chemistry (Baltimore, Md.). 2007, Vol 53, Num 11, pp 1960-1962, issn 0009-9147, 3 p.Article

Myeloid neoplasm with rearrangement of PDGFRA, but with no significant eosinophilia: should we broaden the World Health Organization definition of the entity?RUDZKI, Zbigniew; GILES, Louise; CROSS, Nicholas C. P et al.British journal of haematology. 2012, Vol 156, Num 5, issn 0007-1048, p. 558Article

Molecular basis of myelodysplastic/myeloproliferative neoplasmsREITER, Andreas; INVERNIZZI, Rosangela; CROSS, Nicholas C. P et al.Haematologica (Roma). 2009, Vol 94, Num 12, pp 1634-1638, issn 0390-6078, 5 p.Article

The 8p11 myeloproliferative syndrome: A distinct clinical entity caused by constitutive activation of FGFR1MACDONALD, Donald; REITER, Andreas; CROSS, Nicholas C. P et al.Acta haematologica. 2002, Vol 107, Num 2, pp 101-107, issn 0001-5792Article

Quantitative analysis of SRNPN gene methylation by pyrosequencing as a diagnostic test for prader-willi syndrome and angelman syndromeWHITE, Helen E; DURSTON, Victoria J; HARVEY, John F et al.Clinical chemistry (Baltimore, Md.). 2006, Vol 52, Num 6, pp 1005-1013, issn 0009-9147, 9 p.Article

Modification of British Committee for Standards in Haematology diagnostic criteria for essential thrombocythaemiaHARRISON, Claire N; BUTT, Nauman; CROSS, Nicholas C. P et al.British journal of haematology. 2014, Vol 167, Num 3, pp 421-423, issn 0007-1048, 3 p.Article

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic LeukemiaITZYKSON, Raphaël; KOSMIDER, Olivier; VEY, Norbert et al.Journal of clinical oncology. 2013, Vol 31, Num 19, pp 2428-2436, issn 0732-183X, 9 p.Article

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemiaFORONI, Letizia; WILSON, Gill; CLENCH, Tim et al.British journal of haematology. 2011, Vol 153, Num 2, pp 179-190, issn 0007-1048, 12 p.Article

Persistence of bone marrow micrometastases in patients receiving adjuvant therapy for breast cancer: Results at 4 yearsSLADE, Martin J; SINGH, Anjana; CROSS, Nicholas C. P et al.International journal of cancer. 2005, Vol 114, Num 1, pp 94-100, issn 0020-7136, 7 p.Article

The t(8;9)(p22;p24) is a recurrent abnormality in chronic and acute leukemia that fuses PCM1 to JAK2REITER, Andreas; WALZ, Christoph; VANSTRAELEN, Danny et al.Cancer research (Baltimore). 2005, Vol 65, Num 7, pp 2662-2667, issn 0008-5472, 6 p.Article

The influence of INK4 proteins on growth and self-renewal kinetics of hematopoietic progenitor cellsLEWIS, John L; CHINSWANGWATANAKUL, Wimol; LAM, Eric W.-F et al.Blood. 2001, Vol 97, Num 9, pp 2604-2610, issn 0006-4971Article

EZH2 mutational status predicts poor survival in myelofibrosisGUGLIELMELLI, Paola; BIAMONTE, Flavia; ZOI, Katerina et al.Blood. 2011, Vol 118, Num 19, pp 5227-5234, issn 0006-4971, 8 p.Article

Fusion of PDGFRB to two distinct loci at 3p21 and a third at 12q13 in imatinib-responsive myeloproliferative neoplasmsHIDALGO-CURTIS, Claire; APPERLEY, Jane F; STARK, Anthony et al.British journal of haematology. 2010, Vol 148, Num 2, pp 268-273, issn 0007-1048, 6 p.Article

TFG, a target of chromosome translocations in lymphoma and soft tissue tumors, fuses to GPR128 in healthy individualsCHASE, Andrew; ERNST, Thomas; FIEBIG, Andreas et al.Haematologica (Roma). 2010, Vol 95, Num 1, pp 20-26, issn 0390-6078, 7 p.Article

Evolutional change of karyotype with t(8;9)(p22;p24) and HLA-DR immunophenotype in relapsed acute myeloid leukemiaHUANG, Kuan-Po; CHASE, Andrew J; CROSS, Nicholas C. P et al.International journal of hematology. 2008, Vol 88, Num 2, pp 197-201, issn 0925-5710, 5 p.Article

Characterization of three new imatinib-responsive fusion genes in chronic myeloproliferative disorders generated by disruption of the platelet-derived growth factor receptor β geneWALZ, Christoph; METZGEROTH, Georgia; CROSS, Nicholas C. P et al.Haematologica (Roma). 2007, Vol 92, Num 2, pp 163-169, issn 0390-6078, 7 p.Article

Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disordersDAVID, Marianna; CROSS, Nicholas C. P; HUGUET, Francoise et al.Blood. 2007, Vol 109, Num 1, pp 61-64, issn 0006-4971, 4 p.Article

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disordersJONES, Amy V; KREIL, Sebastian; WHITE, Helen et al.Blood. 2005, Vol 106, Num 6, pp 2162-2168, issn 0006-4971, 7 p.Article

Molecular diagnosis of the myeloproliferative neoplasms: UK guidelines for the detection of JAK2 V617F and other relevant mutationsBENCH, Anthony J; WHITE, Helen E; CLENCH, Tim et al.British journal of haematology. 2013, Vol 160, Num 1, pp 25-34, issn 0007-1048, 10 p.Article

Mutations in SETBP1 are recurrent in myelodysplastic syndromes and often coexist with cytogenetic markers associated with disease progressionFERNANDEZ-MERCADO, Marta; PELLAGATTI, Andrea; BOULTWOOD, Jacqueline et al.British journal of haematology. 2013, Vol 163, Num 2, pp 235-239, issn 0007-1048, 5 p.Article

  • Page / 4